Case Review Form

      * Denotes required field.

      Title

      * First Name

      * Last Name

      * Email Address

      * Phone Number

      Cell Phone Number

      Office Phone Number

      Street Address

      Apartment/Suite

      City

      State

      Zip Code

      Please provide the best method and times to contact you:

      Date of birth of injured person
      (mm-dd-yyyy):

      Name of drug:

      Date you started taking the drug (mm-yyyy):

      Date you stopped taking the drug (mm-yyyy):

      Please describe any side effects:

      Other Info:

      No Yes, I agree to the Parker & Waichman LLP disclaimers.Click here to review all.

      Yes, I would like to receive the Parker & Waichman LLP monthly newsletter, InjuryAlert.

      please do not fill out the field below.

Benzocaine Products Get Blood Disorder Warning in Canada

Filed April 6th, 2012 Laurie

Health Canada is letting Canadians know that it has asked companies to include new risk statements in the packaging and labeling of licensed benzocaine products. In April 2011, the agency reminded the public about possible serious health effects associated with benzocaine, including the blood condition methemoglobinemia.

Canadians are urged to carefully read instructions before using benzocaine products. If, after using a benzocaine product, Canadians experience weakness, confusion, headache, difficulty breathing and/or pale, gray or blue colored skin, they should stop using the product and seek immediate medical attention. Canadians should speak to a physician if they have any questions about a benzocaine product, especially before using it on a child under the age of two.

Benzocaine products are typically found over-the-counter in gels, sprays, swabs, liquids, lotions, lozenges. Very few require a prescription. They are also sometimes used in surgical, dental, and other medical procedures to numb the mouth and throat.

The new risk statement includes added instructions about the risks and safe use of methemoglobinemia. They also include information about how to recognize the signs and symptoms of methemoglobinemia.
Canadians who have experienced adverse events while using a product containing benzocaine should report the event to MedEffect Canada by calling 1-866-234-2345, or visiting their website for instructions on how to report online, by mail, or by fax.

Be Sociable, Share!

Comments are closed.

Click Here Now, to Have an Attorney Answer Your
Medicinal Drug Injuries Questions
No Cost - No Obligation!